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Gut microbiome has been identiﬁed in the past decade as an important factor involved in obesity, but the magnitude of its
contribution to obesity and its related comorbidities is still uncertain. Among the vast quantity of factors attributed to obesity,
environmental, dietary, lifestyle, genetic, and others, the microbiome has aroused curiosity, and the scientiﬁc community has
published many original articles. Most of the studies related to microbiome and obesity have been reported based on the
associations between microbiota and obesity, and the in-depth study of the mechanisms related has been studied mainly in
rodents and exceptionally in humans. Due to the quantity and diverse information published, the need of reviews is mandatory
to recapitulate the relevant achievements. In this systematic review, we provide an overview of the current evidence on the
association between intestinal microbiota and obesity. Additionally, we analyze the eﬀects of an extreme weight loss intervention
such as bariatric surgery on gut microbiota. The review is divided into 2 sections: ﬁrst, the association of obesity and related
metabolic disorders with diﬀerent gut microbiome proﬁles, including metagenomics studies, and second, changes on gut
microbiome after an extreme weight loss intervention such as bariatric surgery.
1. Introduction
Obesity is known to be a major public health problem that
aﬀects more than 1.9 billion adults, which means 39% of
adults are considered obesity and overweight [1]. Estimations
from the noncommunicable diseases (NCD) collaboration
reported that if these trends continue, by 2025, global obesity
prevalence will reach 18% in men and surpass 21% in
women; severe obesity will surpass 6% in men and 9% in
women [2]. Obesity is associated with multiple pathologies,
among them cardiovascular diseases, metabolic syndrome,
and cancer [3].
The latest public statements report the attributable deaths
to obesity. The Global BMI Mortality Collaboration reported
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that mortality increased with bodymass index (BMI) approx-
imately in a log-linear manner and that the associations of
both overweight and obesity with higher all-cause mortality
were broadly consistent in four continents [4].
Another troubling factor is the increase of childhood obe-
sity, which is known to be a risk factor for obesity in adults [5].
Gut microbiota has captured our attention in the last
decade as an element that directly aﬀects our health or dis-
ease status. In particular, it has been implicated in the aetiol-
ogy of obesity [6]. In fact, the composition of gut microbiota
seems to play a role concerning obesity.
Gutmicrobiota is considered as an assortment ofmicroor-
ganisms that inhabit the gastrointestinal tract. The composi-
tion of this microbial community depends on the host, but it
can also bemodiﬁed by exogenous and endogenous events [7].
With regard to the host, these bacteria are symbiotic, and
play an important role in physiological processes, for exam-
ple, in digestion, or they can intervene in the metabolism,
as they can increase energy production from the diet and take
part in the regulation of the fatty acid tissue composition [8].
The diﬀerent bacteria can also induce low-grade inﬂamma-
tion. All these processes are involved in obesity and meta-
bolic disorders.
With the introduction of human whole metagenome
studies, the associations of microbiota and disease were plau-
sible and many have been encountered.
It is known that most of the human’s populations micro-
biota is composed by 5 phyla Bacteroidetes, Firmicutes, Acti-
nobacteria, Proteobacteria, and Verrucomicrobia [9] being
Bacteroidetes and Firmicutes around 90% of the total bacte-
rial species [9, 10].
The composition of the bacterial diversity seems to
change between lean and obese, increasing the number of
Firmicutes to the detriment of Bacteroidetes [9, 11–13] in
obese patients and also in type 2 diabetes, which is pathology
in close relationship to obesity. But some recent studies have
found controversial results [9, 11–15]: studies of association
between microbiota proﬁles and diﬀerent phenotypes or
body mass index have adventured the positive and negative
associations among the diﬀerent phyla that populate the
intestines. The searches of mechanistic pathways involved
in the contribution of microbiota to obesity or vice versa have
been subject for many animal studies [10]. An interesting
ﬁnding was that obesity-resistant germ-free mice become
obese and increase their energy harvest and caloric uptake
after receiving a microbiota transplant [16].
The new era of sequencers has widely unlocked the
acquirement of information. Sequencing of speciﬁc regions
of 16S or 18S ribosomal genes allows the identiﬁcation of
organisms and their relative abundance in puriﬁed DNA
[17]. Thus, the sequencing of gut microbiota with 16S rRNA
made an inﬂexion point in the knowledge and relationship
of the microbial diversity with the diﬀerent physiopatholog-
ical states that intervene in health and disease, allowing the
observation of the behavior of the diﬀerent bacterial phyla,
and genus, links with diﬀerent phenotypes, diﬀerent types
of diets, and obesity in particular [18]. Furthermore, the
development of high throughput DNA sequencing of shot-
gun genomic libraries to assess the microbiome (collection
of all genes in the microbial genomes), such as the Human
Microbiome Project, is aiming to contribute to the assess-
ment of the diversity and relative abundance of our com-
mensal microbiota at diﬀerent sites of our organism and
to the understanding of their role on human health and
disease [19].
Bariatric interventions have been implemented as a solu-
tion to extreme situations of weight gain in the past decades.
The techniques have improved with two main variants: the
Roux-en-Y gastric bypass (RYGB) and the laparoscopic
sleeve gastrectomy (LSG).
RYGB and LSG procedures modify the anatomy of the
gastrointestinal system, which modulates nutrient transit
and impacts gut physiology. They are known to produce a
long-term reduction in body weight and to decrease blood
glucose levels, both of which are relevant to obesity-related
type 2 diabetes and cardiovascular disease. Nevertheless, the
mechanisms implicated in the metabolic improvements asso-
ciated with bariatric surgery are still challenging. [20]
Some studies have pointed to the eﬀect of surgery on the
microbiota diversity as a partial contribution to the resolu-
tion of the metabolic status of these patients [21].
This review focuses on the current evidence of the
associations between the microbiota proﬁle and the indi-
viduals’ phenotypes and on the eﬀect of bariatric surgery
on gut microbiota.
2. Methods
2.1. Eligibility Criteria. We assessed observational human
studies or clinical trials that evaluated the gut microbiota of
individuals who suﬀered from obesity. Obesity was deﬁned
by body mass index (BMI). We also selected observational
studies of extreme weight loss interventions, such as bariatric
surgery, but did not include dietary interventions, because
there is a lack of homogeneity, and many reviews have
already focused on this theme.
We selected the MeSH terms “Obesity” AND “Microbi-
ota,” with the following ﬁlters: language: English, French,
and Spanish; publication date: 5 years from August 20,
2017. The search was performed in MEDLINE accessed by
PubMed. All of them were screened based on the title and
abstract.
Other possible articles were screened and searched on the
reference lists of the selected articles. With the reading of the
title or title and the abstract, we selected observational studies
and clinical trials, and systematic reviews, in humans.
3. Results
3.1. Literature Search. General characteristics of the studies
are as follows: From the 570 articles retrieved from the
search, 83 articles were selected based on the title and
abstract to be read in depth. Finally, 15 studies were included
and are described in Tables 1 and 2. Eleven articles assessed
diﬀerences in the microbiota proﬁle between obese and lean;
most of these studies were performed on adults, but 3 of them
were performed on children. Four articles assessed the eﬀects
on microbiota of bariatric surgery. 68 were discarded
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Table 1: Lean/obese clinical trials.
Study
identiﬁcation
Description N Population description Outcomes
Kasai et al.
2015 [22]
Cross-sectional study
56
(10)
Japanese population: 23
BMI< 20 kg/m2 and 33
BMI≥ 25 kg/m2
Subsample: 4 nonobese and 6
obese subjects
Bacterial diversity was signiﬁcantly greater in
obese subjects compared with nonobese
subjects.
Reduced numbers of Bacteroidetes and a
higher F/B ratio in obese subjects compared
with nonobese subjects.
Microbiota fecal samples
16S DNA sequencing
Metagenome@KIN software
Corresponding OTU identiﬁed
according to T-RFLP
Million et al.
2012 [23]
Cross-sectional study
115 68 obese and 47 controls
L. reuteri was associated with obesity.
M. smithii was depleted in obese subjects.
Some Biﬁdobacterium or Lactobacillus species
were associated with normal weight
(B. animalis).
Microbiota fecal samples
qPCR targeting Firmicutes,
Bacteroidetes, Lactococcus lactis,
Methanobrevibacter smithii, and
Biﬁdobacterium animalis
Haro et al.
2016 [24]
Cross-sectional study
75
39 men and 36 women with
CVD within CORDIOPREV
study
3 groups according to BMI:
BMI< 30, 30<BMI< 33, and
BMI> 33
F/B ratio changed with the BMI and between
genders.
Men had higher F/B ratio under a BMI of 33.
By contrast, men had a signiﬁcantly lower F/B
ratio than women in the BMI> 33 group.
At genera level, BMI> 33: higher Bacteroides
genus in women, but decrease in men.
Baseline fecal samples
16S rRNA sequencing
QIIME software
Lin et al.
2015 [25]
Cross-sectional study
659
Healthy Chinese adults
Asian: normal BMI< 23 (N =
281), overweight 23-<27.5 (N
= 304), and obese> 27.5 (N
= 55)
BMI was not associated with the bacterial
community diversity as assessed by alpha
diversity in the models.
Upper gastrointestinal microbial
diversity
16S rRNA sequencing
HOMIM software
Angelakis
et al. 2015
[26]
Cross-sectional study
10
5 lean subjects: BMI 20.7
5 obese subjects: BMI 36.8
Firmicutes and Actinobacteria were the most
predominant phyla of the bacterial
composition of the duodenal microbiota in
both groups.
The obese group presented a higher
proportion of anaerobic genera and a lesser
proportion of aerobic genera, mostly
associated with the presence of Veillonella,
Bulleidia, and Oribacterium.
Duodenal microbiota
16S rDNA sequencing
Illumina MiSeq
Finucane
et al. 2014
[27]
Review of 4 diﬀerent studies Human
Microbiome Project (HMP) and
MetaHIT
159
HMP project: 24 obese
(BMI> 30) and 123 lean
(BMI< 25) individuals
MetaHIT project: Danish
MetaHIT cohort included 12
individuals (BMI> 35)
The interstudy variability in the taxonomic
composition of stool microbiomes far exceeds
diﬀerences between lean and obese
individuals within studies. No quantitative
association between the continuous BMI
variable and the ratio of B/F. Variation in the
relative abundance of F and B is much larger
among studies than between lean and obese
individuals within any study. MetaHIT and
HMP go in the opposite direction [11].
Goodrich
et al. 2014
[30]
Cross-sectional study
977
Twin population: 416 twin
pairs, mostly females, mean
age 60.6± 0.3 years
N = 433: BMI< 25
N = 322: BMI 25–30
N = 183: BMI> 30
The family Christensenellaceae was
signiﬁcantly enriched in subjects with a
BMI< 25 compared to those with BMI> 30.
Overall, a majority (n = 35) of the OTUs with
highest heritability scores were enriched in
the lean subjects. A subset of OTUs classiﬁed
as Oscillospira were enriched in lean subjects,
and M. smithii, though not signiﬁcantly
heritable, was positively associated with a lean
BMI.
Fecal samples from the twins UK
population
16S rRNA
Illumina MiSeq
QIIME software
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including the reviews which we read but did not include in
the study except if they were systematic (see Figure 1 of
Supplementary Materials).
All the studies had a baseline assessment of the gut
microbiota, and the changes in microbial composition were
assessed as outcomes.
The 11 studies compared a baseline assessment of gut
microbiota from diﬀerent individual phenotypes whereas
the 4 studies which involved bariatric surgery compared the
baseline assessment with the change after surgery at diﬀerent
time points within each subject.
Most of the studies were performed in Europe (75%),
America (33%), and Asia (25%).
Several molecular biology techniques were used to assess
the characterization of the gut microbiome: denaturing gradi-
ent gel electrophoresis (DGGE), ﬂuorescence in situ hybridi-
zation probes (FISH), metagenomics shotgun sequencing,
and characterization of the 16S rRNA genes in a sample, and
groups speciﬁc real-time polymerase chain reaction (PCR)
are some of the assays. Some studies havemade a step forward
and published results of functional analysis of the gut micro-
biota and metabolome. We have focused on the analysis of
the diversity of microbiota among BMI.
With regard to the time of publication, more than 50%
were published in the last 2 years 2015–2017.
3.1.1. The Association of Obesity and Related Metabolic
Disorders with Diﬀerent Gut Microbiome Proﬁles. Among
the latest studies on microbiota proﬁle between lean and
obese patients, several studies searched for diﬀerential gut
microbiota signatures associated with obesity. We found 11
interesting studies, which compare microbiota in individuals
with diﬀerent BMIs.
The ﬁrst reported study observed that the bacterial diver-
sity was signiﬁcantly greater in obese subjects compared with
nonobese subjects [22]. Next-generation sequencing revealed
that obese and nonobese subjects had diﬀerent gut microbi-
ota compositions and that certain bacterial species were sig-
niﬁcantly associated with each group. This study also agrees
that the ratio Firmicutes/Bacteroidetes (F/B) was higher in
obese subjects and also overweight subjects (BMI> 25) [22].
In the case of the individuals who suﬀered from obesity,
there was a strong association with the following bacterial
species from the Firmicutes phylum: Blautia hydrogenotoro-
phica, Coprococcus catus, Eubacterium ventriosum, Rumino-
coccus bromii, and Ruminococcus obeum. On the other hand,
Table 1: Continued.
Study
identiﬁcation
Description N Population description Outcomes
Bondia-Pons
et al. [35]
Cross-sectional study
50
16 healthy monozygotic twin
pairs discordant for weight
(BMI diﬀerence> 3 kg/m2)
Control pairs: nine
concordant monozygotic
pairs
No diﬀerences in fecal bacterial diversity were
detected when comparing cotwins discordant
for weight. We found that within-pair
similarity is a dominant factor in the
metabolic postprandial response,
independent of acquired obesity.
Fecal samples
Diversity of the major bacterial groups
by using 5 diﬀerent validated bacterial
group-speciﬁc DGGE methods
Murugesan
et al. [31]
Cross-sectional study 190
190 unrelated Mexican
children
9–11 years old
81 normal
29 overweight
80 obese
No statistical signiﬁcant diﬀerences in
abundance of phylum.
Ignacio et al.
[32]
Cross-sectional study 84
30 obese, 24 overweight, and
30 lean children
(3–11 years old)
B. fragilis group and Lactobacillus spp. were
found at high concentrations in obese and
overweight children when compared with the
lean ones and positively correlated with BMI.
Biﬁdobacterium spp. were found in higher
numbers in the lean group than the
overweight and obese ones. Furthermore, a
negative correlation between BMI and
Biﬁdobacterium spp. copy number was
observed.
Hu et al. [33]
Cross-sectional study fecal samples
from 67 obese (BMI> 30 kg/m2) and
67 normal (BMI< 25 kg/m2)
individuals
134
Korean adolescents aged
13–16 years
No signiﬁcant diﬀerences in the
Bacteroidetes, Firmicutes, and Proteobacteria
populations in samples from normal and
obese adolescents at the phylum level,
although the proportion of Bacteroides was
highest in normal children (45%), whereas
that in obese was 25%. Conversely, the
proportion of Prevotella in BMI< 25 was
16%; obese adolescents (35%).
T-RFLP reference human fecal microbiota proﬁling; qPCR: quantitative PCR; CVD: cardiovascular disease; DGGE: denaturing gradient gel electrophoresis.
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in the lean individuals, there was a larger proportion of the
Bacteroidetes phylum species Bacteroides faecichinchillae
and Bacteroides thetaiotaomicron and also Firmicutes Blau-
tia wexlerae, Clostridium bolteae, and Flavonifractor plautii.
In agreement with these results, another study with a focused
approach also observed that Firmicutes (L. reuteri) was asso-
ciated with obesity and another genus Methanobrevibacter
smithii was decreased. In this case, the authors focused
directly on targeting Firmicutes, Bacteroidetes, Methanobre-
vibacter smithii, Lactococcus lactis, and Biﬁdobacterium ani-
malis, by quantitative PCR and cultures [23].
Furthermore, a third party was introduced with gender,
in a study with the aim at observing diﬀerences in microbiota
between genders, but reported that the diﬀerences in gender
could be inﬂuenced by BMI [24]. They observed that the F/
B ratio changed along with BMI, as it had been described
before [22], and also by gender. The F/B ratio tended to
increase with BMI up to >33 and decreased surprisingly when
BMI was >33. In men, Bacteroidetes genus decreased when
the BMI increased, but no changes were observed in women.
The methodologies diﬀer between these studies. In our
sequence of studies, the three assessments were performed
Table 2: Bariatric surgery clinical trials.
Study
identiﬁcation
Description N Population description Outcomes
Palleja et al.
2016 [36]
Longitudinal observational study
13
Participants were recruited for
bariatric surgery: BMI> 40 kg/m2 or
BMI> 35 kg/m2 with T2D/
hypertension
Gut microbial diversity increased within
the ﬁrst 3 months after RYGB and
remained high 1 year later. RYGB led to
altered relative abundances of 31 species:
Escherichia coli, Klebsiella pneumoniae,
Veillonella spp., Streptococcus spp.,
Alistipes spp., and Akkermansia
muciniphila.
Fecal samples
Quantiﬁcation of gut microbiomes at
baseline (n = 13), 3 months (n = 12)
after RYGB, and 12 months (n = 8)
after RYGB
16S rDNA shotgun sequencing
Tremaroli
et al. 2015
[29]
Clinical trial
21
Weight-stable women 9 years after
randomization to either RYGB or
LSG and matched for weight and fat
mass loss
Control: 2 groups of nonoperated
women with BMI matched to
patients’ (1) presurgical BMI and (2)
postsurgical BMI
Signiﬁcant diﬀerences in microbiota
composition for RYGB versus OBS
samples but not for LSG versus OBS or
RYGB versus LSG.
29 microbial genera diﬀered signiﬁcantly
between RYGB and controls:
↑ Gammaproteobacteria class and ↓ three
species in the Firmicutes phylum
(C. diﬃcile, C. hiranonis, and
G. sanguinis).
At the genus level:
↑ Proteobacteria (Escherichia, Klebsiella,
and Pseudomonas) in RYGB.
No diﬀerent microbiota proﬁles for RYGB
and LSG patients.
Fecal samples
16S rDNA
Illumina HiSeq 2000
Shotgun sequencing
Damms-
Machado
et al. 2015
[34]
Clinical trial
10
10 unrelated subjects with obesity
grade III at 3 time points:
(1) baseline
(2) 3 months after LSG
(3) 6 months after LSG (N = 5) or
dietary weight loss regimen (N = 5)
Both interventions resulted in changes of
the B/F ratio but with an inverse
relationship between the main phyla.
LSG: ↑ Bacteroidetes and ↓Firmicutes
Dietary intervention: ↓ Bacteroidetes and
↑Firmicutes
In LSG: Bacteroidetes correlated
negatively with weight. Firmicutes
positively correlated with weight.
Fecal samples
SOLiD long-mate-paired shotgun
sequencing
Graessler
et al. 2013
[37]
Clinical trial
6
3 men and 3 women, recruited for
RYGB
38–53 years
Preoperative BMI 40.9–52.1
↓ Firmicutes, Bacteroidetes,
Actinobacteria, and Cyanobacteria.
However, the ratios of B/F shifted from
0.99 to 1.31, showing an apparent increase.
↑ Proteobacteria, Verrucomicrobia, and
Fusobacteria.
3 months after RYGB, ↑ E. cancerogenus,
Veillonella parvula, V. dispar, Shigella
boydii, and Salmonella entérica.
Postoperative abundances of these species
were also signiﬁcantly higher than those in
lean controls.
Fecal samples
16S rDNA
Illumina HiSeq 2000
Shotgun sequencing
BMI: body mass index, expressed as kg/m2; RYGB: Roux-en-Y gastric bypass; LSG: sleeve gastrectomy.
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in fecal samples of adult individuals who suﬀered from obe-
sity comparing with normal weight adult individuals. The
two ﬁrst studies were performed by metabarcoding 16S
rRNA [22, 24], and the third one used a diﬀerent methodol-
ogy with a focused approach on PCR and cultures [23].
Two of these studies were performed in Europe and the
other one in Asia [22]; this fact is important because BMI
categories diﬀer between Asia and Europe.
Another two publications analyzed the upper gastrointes-
tinal microbial diversity [25, 26] compared to the above-
mentioned studies that assessed microbiota from fecal sam-
ples. None of these two studies of microbiota from the upper
gastrointestinal tract and duodenum found diﬀerences in the
microbiota diversity in terms of phyla, which may suggest
that the impact of obesity might aﬀect the lower portions of
the gastrointestinal tract.
The analysis of the upper gastrointestinal microbial
diversity did not ﬁnd association among the bacterial com-
munity with obesity. Alpha diversity was not associated with
obesity but beta diversity was. The microbiome was charac-
terized using the 16S rRNA gene DNA microarray (the
HOMIM array), which uses 16S rRNA-based oligonucleotide
probes printed on glass slides. They also used another
approach to search for diversity in the community and found
that BMI was not associated with the bacterial community
diversity as assessed by alpha diversity in their models after
adjusting for multiple potential confounders. However,
BMI was signiﬁcantly associated with the variation in the
community composition, as assessed by multiple beta-
diversity parameters. As a limitation in this study, the micro-
array was only semiquantitative and contained a limited
number of bacterial species. As a microarray based on the
16S rRNA gene, this assay did not produce data that could
be used to determine categories of bacterial functions.
Another study performed in upper gastrointestinal
tract, studying the microbiota of duodenum [26], also
reported that there were no diﬀerences between obese and
lean among the microbiota phyla. The only diﬀerences
found were in the relative abundance of aerobic and anaer-
obic, being the obese population, presenting a higher
proportion of anaerobic genera, mostly Veillonella, Bullei-
dia, and Oribacterium.
A very interesting study [27] aimed at conﬁrming some
previous published results of studies of considerable magni-
tude, such as the HMP (Human Microbiome Project from
the NIH) and the MetaHIT project, and also at comparing
them with two previous studies of high reputation [11, 28].
The researchers analyzed all the results together and could
not ﬁnd an association, so no diﬀerence was found between
obese and lean individuals in their relative abundance of Bac-
teroidetes or Firmicutes. And interestingly, it was found that
the variation in the relative abundance of Firmicutes and
Bacteroidetes was much larger among studies than between
lean and individuals who suﬀered from obesity within any
study. The relevance of this speciﬁc article is that it gives sci-
entiﬁc justiﬁcation that there are some real statistically
proved discrepancies among the studies and that MetaHIT
and HMP not only do not recapitulate the ﬁndings observed
but even go in the opposite direction. So, at this point, no
signiﬁcant association between BMI and taxonomic compo-
sition at the phylum level could be found.
Other studies have been performed in twin pairs, which
provide more information about the heritability of microbi-
ota: one of the studies analyzed fecal samples of healthy
monozygotic (MZ) twin pairs which were discordant in
weight and compared them with other concordant BMI twin
pairs [29]. Their results demonstrated that within-pair simi-
larity was a dominant factor independent of acquired obesity.
Another study [30] that wanted to assess which speciﬁc
taxa within the gut microbiome are heritable and to what
extent and how do heritable microbes relate to host BMI.
They compared fecal samples from twins and found a
greater similarity of microbiota within twin pairs com-
pared to unrelated individuals.
The most heritable taxon overall was the family Christen-
senellaceae (Firmicutes phylum), which associates with a low
BMI. The family Christensenellaceae was signiﬁcantly
enriched in subjects with a lean BMI (<25) compared to
those with an obese BMI (>30).
Within the three most dominant bacterial families, from
the Firmicutes phylum and families Ruminococcaceae and
Lachnospiraceae, there was a signiﬁcantly greater similarity
for MZ twins compared to dizygotic (DZ) twins, in contrast
with the Bacteroidaceae family, in which MZ and DZ twins
had similar pairwise diversity. Therefore, Firmicutes seems
to have more heritability.
Three studies have focused their attention on gut micro-
biota association to obesity in children. Two of them were
performed in Central and South America in children up to
11 years old. Another study performed in youngsters aged
13–16 was performed in Asia.
A Mexican study [31] in 190 children did not ﬁnd statis-
tical diﬀerences between phyla. Despite that, several genera
and families, from the Firmicutes phylum as well as some
Enterobacteriaceae, increased in overweight and obese chil-
dren: the genus Faecalibacterium sp., the family Lachnospir-
aceae, and the genus Roseburia sp. A decrease in the genus
Succinivibrio sp., the genus Erwinia sp. from the Proteobac-
teria phylum, and the genus Oscillospira sp. from the Firmi-
cutes phylum was found.
The genus Blautia sp., the genus Coprococcus sp., and the
family Enterobacteriaceae from the Firmicutes phylum were
clearly increased in the overweight phenotype. Another study
in 30 obese children (3–11 years) found that there were high
concentrations of B. fragilis group and Lactobacillus sp. in
obese and overweight children when compared with the lean
ones, with the fecal concentrations positively correlated with
BMI [32]. Furthermore, a negative correlation between BMI
and Biﬁdobacterium spp. was observed.
In contrast, another study in Korean adolescents did not
ﬁnd any signiﬁcant diﬀerences in the Bacteroidetes, Firmi-
cutes, and Proteobacteria populations in samples from nor-
mal and obese adolescents at the phylum level [33].
However, there was a marked diﬀerence in the average pro-
portions of Bacteroides and Prevotella between normal and
obese samples at the genus level. This trend persisted at the
family level. A signiﬁcant association was found between
the compositions of several bacterial taxa and child obesity,
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with the proportion of Bacteroides highest in normal children
compared to those who suﬀered from obesity.
With regard to the metabolically healthy obese sub-
ject, deﬁned as those subjects which have normalized
levels of the parameters that are used to deﬁne metabolic
syndrome (blood pressure, HDL cholesterol levels, glycae-
mia, and visceral fat), there is no literature characterizing
the microbiota proﬁle of these subjects. Such ﬁndings
would be interesting to understand whether the microbial
diversity has a metabolic role in individuals who suﬀered
from obesity.
3.1.2. Bariatric Surgery Weight Loss Impact on Gut
Microbiota. We have found 4 articles in the last 5 years to
look for the eﬀect of bariatric surgery on the microbiota pro-
ﬁle. All four studies analyze the results comparing with a
baseline before the intervention and have a follow-up of 6
months to 1 year. Two of them studied the changes after
RYGB surgery, another one LSG, and another one included
both types of surgery.
Palleja et al. found that after RYGB surgery, the microbial
diversity increased and this diversity was maintained one
year after surgery [36]. Another study that included the two
types of surgery only found an increased diversity in the
RYGB group whether there were no diﬀerences between
individuals who suﬀered from obesity, and the LSG group,
which lead us to think that maybe the type of surgery and
not the weight loss is playing a role in the diversity.
Opposite to this assumption, another study in which BS
was LSG, compared to a diet, showed that both interventions
resulted in changes of the Bacteroidetes/Firmicutes ratio but
with an inverse relationship between the main phyla [34].
While LSG increased Bacteroidetes and decreased Firmi-
cutes, the dietary intervention resulted in reduced Bacteroi-
detes in favour of Firmicutes. The Bacteroidetes/Firmicutes
ratio decreased following dietary intervention, whereas in
the LSG group, this ratio increased. In the LSG group, the
number of Bacteroidetes showed a negative correlation with
body weight while Firmicutes numbers were positively corre-
lated with body.
Finally, another study that only recruited patients with a
RYGB found that four of the top seven high abundance
phyla were decreased in postoperative samples, including
Firmicutes (from 47.2 to 34.2%), Bacteroidetes (from 46.9
to 44.7%), Actinobacteria (from 1.7 to 1.2%), and Cyano-
bacteria (from 0.10 to 0.06%). However, the ratios of Bac-
teroidetes/Firmicutes shifted from 0.99 to 1.31, showing an
apparent increase.
4. Discussion
This review intends to recapitulate the information obtained
in the last 5 years on the association of gut microbiota with
obesity and an extreme weight loss intervention. One of the
important points of discussion is whether obesity is associ-
ated with more or less microbiota diversity and whether the
ratio F/B is increased with obesity.
Still some controversial data have been published in the
past 5 years. Whereas previous relevant studies [28] had
found lower microbiota diversity in those individuals who
suﬀered from obesity, compared to lean individuals, our
review depicts that most of the studies did not ﬁnd diﬀerences
concerning bacterial diversity in unrelated population study-
ing the upper GI tract [25], weight discordant twins [35], or
children [31, 33]. One of the reasons for not ﬁnding associa-
tions in the upper gastrointestinal tract might be also due to
the less abundant number of bacteria which exponentially
increase from the proximal to the distal gastrointestinal tract
and so being the colon where most of the bacteria are har-
boured [17]. Also in the case of the studies on children [31–
33], the gut microbiota starts at birth, reaches maximum
diversity at adolescence, and remains stable until later stages
of life [17], or studies age span was between 3 and 16 years
old, which would justify the diversity of the results. Also, bar-
iatric surgery in any of its varieties increased gut microbial
diversity [36, 37].
Among the presented studies, one study observed an
increase in alpha diversity which was also related to an
increase in the ratio F/B [22]. In concordance with this ﬁnd-
ing, it seemed to be described more abundance of Firmicutes
in obese subjects even with diﬀerent types of methodologies
[23], and also this ratio seemed to be higher in women when
BMI was increased [24] or in a speciﬁc family within the
phylum [23]. These observations follow the fact that after
BS the ratio decreases with a decrease of Firmicutes and an
increase of Bacteroidetes [29, 34] and as it had be previously
reported [16].
Among the limitations of the studies, the new and grow-
ing advance in methodologies such as next-generation
sequencing has arouse many diﬀerent possibilities in terms
of laboratory work and data management and software, as
mentioned above in a comparative study [27] which clearly
shows how the intervariability between studies is greater than
the diﬀerence between lean and individuals who suﬀered
from obesity.
5. Conclusion
This review systematically assessed studies of association
between obesity and microbial diversity of the gastrointesti-
nal tract and bariatric surgery interventions in obese and
overweight patients. Obesity is associated with diﬀerent pro-
ﬁles of gut microbiota, but studies seem not to ﬁnd enough
consistency on the results, most probably because it can be
inﬂuenced by several factors, among them the diﬀerent
methodologies and growing data management knowledge.
Also, we review that bariatric surgery intervention for weight
loss impacts the gut microbiota composition.
Further trials and the evolution of this shotgun sequenc-
ing data management are needed to draw conclusions about
the role of microbial diversity in obesity.
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